» Articles » PMID: 38856758

Thick Mesopancreas is a Novel Predictor of Surgical Outcomes of Patients Who Undergo Pancreaticoduodenectomy

Overview
Specialty General Surgery
Date 2024 Jun 10
PMID 38856758
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Mesopancreas resection is a crucial but difficult procedure when performing pancreaticoduodenectomy. This study evaluated the influence of mesopancreas thickness on surgical outcomes in patients undergoing pancreaticoduodenectomy.

Methods: We measured the thickness of the fat tissue on the right side of the superior mesenteric artery from the dorsal margin of the confluence of the superior mesenteric vein and portal vein to the ventral margin of the left renal vein on preoperative contrast-enhanced computed tomography and defined it as the mesopancreas thickness. We evaluated the correlation between mesopancreas thickness and intraoperative and postoperative variables in 357 patients who underwent pancreaticoduodenectomy.

Results: Multivariate analysis revealed that a thick mesopancreas was significantly associated with a long operative time (β = 10.361; 95% confidence interval, 0.370-20.353, p = 0.042), high estimated blood loss (β = 36.038; 95% confidence interval, -27.192-99.268, p = 0.013), and a low number of resected lymph nodes (β = -1.551; 95% confidence interval, -2.662--0.439, p = 0.006). This analysis further revealed that thick mesopancreas was a significant risk factor for overall morbidity (odds ratio 2.170; 95% confidence interval 1.340-3.520, p = 0.002), major morbidity (odds ratio 2.430; 95% confidence interval 1.360-4.340, p = 0.003), and a longer hospital stay (β = 2.386; 95% confidence interval 0.299-4.474, p = 0.025).

Conclusion: A thick mesopancreas could predict a longer operation time, higher estimated blood loss, fewer resected lymph nodes, more frequent overall and major morbidities, and a longer hospital stay in patients who underwent pancreaticoduodenectomy more precisely than the body mass index.

References
1.
Kimura W, Miyata H, Gotoh M, Hirai I, Kenjo A, Kitagawa Y . A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy. Ann Surg. 2013; 259(4):773-80. DOI: 10.1097/SLA.0000000000000263. View

2.
Aoki S, Miyata H, Konno H, Gotoh M, Motoi F, Kumamaru H . Risk factors of serious postoperative complications after pancreaticoduodenectomy and risk calculators for predicting postoperative complications: a nationwide study of 17,564 patients in Japan. J Hepatobiliary Pancreat Sci. 2017; 24(5):243-251. PMC: 5516144. DOI: 10.1002/jhbp.438. View

3.
Pedrazzoli S . Pancreatoduodenectomy (PD) and postoperative pancreatic fistula (POPF): A systematic review and analysis of the POPF-related mortality rate in 60,739 patients retrieved from the English literature published between 1990 and 2015. Medicine (Baltimore). 2017; 96(19):e6858. PMC: 5428612. DOI: 10.1097/MD.0000000000006858. View

4.
Del Valle J, Mahvi D, Fairweather M, Wang J, Clancy T, Ashley S . The improvement in post-operative mortality following pancreaticoduodenectomy between 2006 and 2016 is associated with an improvement in the ability to rescue patients after major morbidity, not in the rate of major morbidity. HPB (Oxford). 2020; 23(3):434-443. DOI: 10.1016/j.hpb.2020.07.013. View

5.
Ramsey A, Martin R . Body mass index and outcomes from pancreatic resection: a review and meta-analysis. J Gastrointest Surg. 2011; 15(9):1633-42. DOI: 10.1007/s11605-011-1502-1. View